Plasma coenzyme Q10 is increased during gestational diabetes

Diabetes Research and Clinical Practice

Volumn 94, Issue 2, 2011, Pages 230-235

  Giannubilo, Stefano Raffaele ^a   Tiano, Luca ^a   Cecchi, Stefano ^a   Principi, Federica ^a   Tranquilli, Andrea Luigi ^a   Littarru, Gian Paolo ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Coenzyme Q10; Gestational diabetes mellitus; ORAC; Pregnancy

Indexed keywords

CHOLESTEROL; UBIDECARENONE; BIOLOGICAL MARKER; DRUG DERIVATIVE; INSULIN; UBIQUINONE;

ADULT; ARTICLE; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GESTATION PERIOD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSULIN RESISTANCE; LONGITUDINAL STUDY; OXIDATIVE STRESS; PREGNANCY DIABETES MELLITUS; THIRD TRIMESTER PREGNANCY; BLOOD; CASE CONTROL STUDY; ENZYMOLOGY; GLUCOSE BLOOD LEVEL; ITALY; METABOLISM; PREGNANCY;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES, GESTATIONAL; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; ITALY; LONGITUDINAL STUDIES; OXIDATIVE STRESS; PREGNANCY; PREGNANCY TRIMESTER, THIRD; UBIQUINONE;

EID: 81255136154     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.07.007     Document Type: Article

References (39)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus (Position Statement). Diabetes Care 2009, 32:S62-S67.
2. King H. Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care 1998, 21:B9-B13.
3. Pettitt D.J., Nelson R.G., Saad M.F., Bennett P.H., Knowler W.C. Diabetes and obesity in the offspring of Pima Indian women with diabetes during pregnancy. Diabetes Care 1993, 16:310-314.
4. Peuchant E., Brun J.L., Rigalleau V., Dubourg L., Thomas M.J., Daniel M.Y., et al. Oxidative and antioxidative status in pregnant women with either gestational or type 1 diabetes. Clin Biochem 2004, 37:293-298.
5. Therond P., Bonnefont-Rousselot D., Davit-Spraul A., Conti M., Legrand A. Biomarkers of oxidative stress: an analytical approach. Curr Opin Clin Nutr Metab Care 2000, 3:373-384.
6. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
7. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a " causal" antioxidant therapy. Diabetes Care 2003, 26:1589-1596.
8. 10 on experimental atherosclerosis and chemical composition and quality of atheroma in rabbits. Atherosclerosis 2000, 148:275-282.
9. Lonnrot K., Porsti I., Alho H., Wu X.M., Hervonen A., Tolvanen J.P. Control of arterial tone after long-term coenzyme Q (10) supplementation in senescent rats. Br J Pharmacol 1998, 124:1500-1506.
10. 10 protects coronary endothelial function from ischemia reperfusion injury via an antioxidant effect. Surgery 1996, 120:189-196.
11. 10 improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus. Diabetologia 2002, 45:420-426.
12. 10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study. Eur Heart J 2007, 28:2249-2255.
13. 10 alpha-tocopherol and free cholesterol levels in sera from diabetic patients. Biochemical and clinical aspects of coenzyme Q 1991, 151-158. Elsevier Science, Amsterdam. K. Folkers, G. Littarru, T. Yamagami (Eds.).
14. Akai T., Fujii S. Blood glucose monitoring system. Rinsho Byori 1984, 32:1058-1064.
15. Matthews D.R., Hosker J.P. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
16. Gillespie K.M., Chae J.M., Ainsworth E.A. Rapid measurement of total antioxidant capacity in plants. Nat Protoc 2007, 2:867-870.
17. Schrauwen P., Hesselink M.K.C. Oxidative capacity, lipotoxicity and mitochondrial damage in type 2 diabetes. Diabetes 2004, 53:1412-1417.
18. Ceriello A. Oxidative stress and glycemic regulation. Metabolism 2000, 49:27-29.
19. McCarty M.F. Can correction of sub-optimal coenzyme Q status improve beta-cell function in type II diabetics?. Med Hypotheses 1999, 52:397-400.
20. West I.C. Radicals and oxidative stress in diabetes. Diabet Med 2000, 17:171-180.
21. Kinalski M., Sledziewski A., Telejko B., Kowalska I., Kretowski A., Zarzycki W., et al. Lipid peroxidation, antioxidant defence and acid-base status in cord blood at birth: the influence of diabetes. Horm Metab Res 2001, 33:227-231.
22. Nakamura S., Takamura T., Matsuzawa-Nagata N., Takayama H., Misu H., Noda H., et al. Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria. J Biol Chem 2009, 284:14809-14818.
23. Fridlyand L.E., Philipson L.H. Does the glucose-dependent insulin secretion mechanism itself cause oxidative stress in pancreatic beta-cells?. Diabetes 2004, 53:1942-1948.
24. Weijers R.N., Bekedam D.J. Relationship between gestational diabetes mellitus and type 2 diabetes: evidence of mitochondrial dysfunction. Clin Chem 2007, 53:377-383.
25. 10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 2006, 40:445-453.
26. 10 ratio as a possible marker of increased risk for atherosclerosis. Biofactors 1999, 9:231-240.
27. 10. Diabet Med 2006, 23:1344-1349.
28. Bendahan D., Desnuelle C., Vanuxem D., Confort-Gouny S., Figarella-Branger D., Pellissier J.F., et al. 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies. Neurology 1992, 42:1203-1208.
29. Asayama K., Uchida N., Nakane T., Hayashibe H., Dobashi K., Amemiya S., et al. Antioxidants in the serum of children with insulin-dependent diabetes mellitus. Free Radic Biol Med 1993, 15:597-602.
30. Paolisso G., D'Amore A., Volpe C., Balbi V., Saccomanno F., Galzerano D., et al. Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients. Metabolism 1994, 43:1426-1429.
31. 10 and insulin secretion in vitro. Diabetes Res Clin Pract 1996, 33:135-136.
32. 10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation. Diabetologia 1998, 41:584-588.
33. Silvestre-Aillaud P., BenDahan D., Paquis-Fluckinger V., Pouget J., Pelissier J.F., Desnuelle C., et al. Could coenzyme Q and l-carnitine be a treatment for diabetes secondary to 3243 mutation of mtDNA?. Diabetologia 1995, 38:1485-1486.
34. Eriksson J.W. Metabolic stress in insulin's target cells leads to ROS accumulation-a hypothetical common pathway causing insulin resistance. FEBS Lett 2007, 581:3734-3742.
35. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002, 106:2067-2072.
36. Karacay O., Sepici-Dincel A., Karcaaltincaba D., Sahin D., Yalvaç S., Akyol M., et al. A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24-36 weeks of gestation. Diabetes Res Clin Pract 2010, 89:231-238.
37. 10 in pregnancy. Fetal Diagn Ther 1996, 11:264-270.
38. Zhang Y., Aberg F., Appelkvist E.-L., Dallner G., Ernster L. Uptake of dietary coenzyme Q supplement is limited in rats. J Nutr 1995, 125:446-453.
39. Lass A., Sohal R.S. Electron transport-linked ubiquinone-dependent recycling of α-tocopherol inhibits autooxidation of mitochondrial membranes. Arch Biochem Biophys 1998, 352:229-236.